Hoth Therapeutics has deployed the OpenAI API to support IND-enabling development of HT-KIT, its orphan-designated therapy targeting KIT-driven cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results